0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

sarclisa_img

Click to enlarge

Previous product

Pemazyre (pemigatinib) CHF38,050.29

Back to products

Next product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/onureg_img.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Onureg (azacitidine) CHF34,970.00

Sarclisa (isatuximab)

CHF1,348.75

Sarclisa (isatuximab) is a medication used in combination with pomalidomide and dexamethasone or with carfilzomib and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM).

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Sarclisa (isatuximab)”

Start typing to see products you are looking for.

No account yet?

Create an Account